Business Services Industry

Tekmira Pharmaceuticals Presents Data on Improved Drug Delivery Technology at International RNAi Conference.(Conference news)

Canadian Corporate News, March, 2008

Content provided
in partnership with

VANCOUVER, BRITISH COLUMBIA, Mar 28, 2008 (Marketwire via COMTEX) -- Tekmira Pharmaceuticals Corporation ("Tekmira") (TSX:TKM) announced today that a new second-generation formulation of the Company's liposomal drug delivery technology has the potential to bring a 10-fold increase in potency to RNA interference (RNAi) drugs that are administered intravenously.

The preclinical data are being presented at the "RNAi, MicroRNA, and Non-Coding RNA" Keystone Symposium held March 25-30, 2008 in Whistler, British Columbia.

Most Popular Articles in Business: Research and Markets : Tesco Plc - SWOT Framework Analysis; Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors; eBay made easy: ready to start an eBay business? These 5 simple steps will ...; Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...; Wal-Mart's newest distribution center opened last month near the southwest ...; More »

RNAi drugs have the potential to treat ...

Read the rest of this article with a Free Trial at HighBeam Research.

Business Services Industry

Tekmira Pharmaceuticals Presents Data on Improved Drug Delivery Technology at International RNAi Conference.(Conference news)

Canadian Corporate News, March, 2008

Find Research Guides for:

Find Featured Titles for: Health

Most Popular Articles in Business

Most Popular Publications in Business